SCHEMBL9204635

SCHEMBL9204635

CCCCc1ncc(CNC(Cc2ccccc2)C(=O)OC)n1Cc1ccccc1Cl

nearest known ligand 0.65

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ AGTR1 P30556 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9204638 1.00 AGTR1 (0.52) AGTR1
SCHEMBL9214266 0.92 — —
SCHEMBL9214275 0.92 — —
SCHEMBL7432919 0.92 AGTR1 (0.60) AGTR1
SCHEMBL7432923 0.92 AGTR1 (0.60) AGTR1
SCHEMBL9205029 0.89 AGTR1 (0.59) AGTR1
SCHEMBL9205035 0.89 AGTR1 (0.59) AGTR1
SCHEMBL9475007 0.88 — —
SCHEMBL9473261 0.88 — —
SCHEMBL9213930 0.88 AGTR1 (0.55) AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0427463-B1 Substituted N-(imidazolyl)alkyl alanine derivatives SMITHKLINE BEECHAM CORP (US) 1995-03-08 — — EP disclosed
US-5248689-A Hypotensive agents, congestive heart failure, renal failure or glaucoma SMITHKLINE BEECHAM CORPORATION (US) 1993-09-28 — — US disclosed
EP-0427463-A1 Substituted N-(imidazolyl)alkyl alanine derivatives SMITHKLINE BEECHAM CORPORATION (US) 1991-05-15 — — EP disclosed
Send feedback